Investigating the effect of a ketogenic diet on the treatment process of patients with non-metastatic rectal cancer requiring chemoradiotherapy
Phase 1
Recruiting
- Conditions
- Rectal cancer, ketogenic diet.
- Registration Number
- IRCT20240410061465N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
People with rectal cancer
People with biopsy- and scan-confirmed rectal cancer without evidence of metastasis
Exclusion Criteria
Patient non-cooperation during treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the effect of a ketogenic diet on rectal cancer cell metabolism and chemoradiotherapy response?
How does a ketogenic diet compare to standard-of-care treatments in improving chemoradiotherapy outcomes for non-metastatic rectal cancer patients?
Which biomarkers are associated with patient selection and response prediction to ketogenic diet interventions in rectal cancer?
What are the potential adverse events of a ketogenic diet in rectal cancer patients undergoing chemoradiotherapy and how can they be managed?
Are there any combination approaches involving ketogenic diet and targeted therapies for rectal cancer treatment?